tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MoonLake Immunotherapeutics initiated with a Buy at Bryan Garnier

Bryan Garnier analyst Alex Cogut initiated coverage of MoonLake Immunotherapeutics with a Buy rating and $22 price target.

Meet Your ETF AI Analyst

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on MLTX:

Disclaimer & DisclosureReport an Issue

1